ZIOP Stock Ownership Activity

ZIOPHARM ONCOLOGY INC 13F holders

No value investing guru has made any change to the ZIOPHARM ONCOLOGY INC (ZIOP) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying ZIOP now?

According to the latest SEC filing(s) ZIOPHARM ONCOLOGY INC (ZIOP) has not been purchased by any super investor.

To see more about who is investing in ZIOPHARM ONCOLOGY INC (ZIOP), please go to the ZIOP ownership page.

2021 Q3 (1 result)
Bill Miller
-100.00%
-10,317,698
-0.93%
0.00%
Current price: $0.87 67.04% Reported price*: $2.64
2021 Q2 (1 result)
Bill Miller
-12.82%
-1,516,969
-0.10%
0.00%
Current price: $0.87 67.04% Reported price*: $2.64
2021 Q1 (1 result)
Bill Miller
-5.07%
-631,581
-0.06%
1.21%
Current price: $0.87 75.83% Reported price*: $3.60
2020 Q4 (1 result)
Bill Miller
+0.65%
+80,662
+0.01%
1.06%
Current price: $0.87 65.48% Reported price*: $2.52
2020 Q3 (1 result)
Bill Miller
-1.86%
-234,144
-0.02%
1.24%
Current price: $0.87 65.48% Reported price*: $2.52
2020 Q2 (1 result)
Bill Miller
-1.85%
-237,305
-0.03%
1.84%
Current price: $0.87 73.48% Reported price*: $3.28
2020 Q1 (1 result)
Bill Miller
+0.96%
+122,800
+0.02%
2.03%
Current price: $0.87 64.49% Reported price*: $2.45
2019 Q4 (1 result)
Bill Miller
-1.92%
-248,911
-0.04%
2.15%
Current price: $0.87 81.57% Reported price*: $4.72
2019 Q3 (1 result)
Bill Miller
+40.52%
+3,743,996
+0.65%
2.25%
Current price: $0.87 79.67% Reported price*: $4.28
2019 Q1 (1 result)
Bill Miller
-0.28%
-25,550
-0.00%
1.41%
Current price: $0.87 77.40% Reported price*: $3.85
2018 Q4 (1 result)
Bill Miller
+92.31%
+4,447,154
+0.36%
0.76%
Current price: $0.87 51.49% Reported price*: $1.79
2018 Q3 (1 result)
Bill Miller
-2.02%
-99,125
-0.01%
0.50%
Current price: $0.87 72.81% Reported price*: $3.20
2018 Q2 (1 result)
Bill Miller
-2.41%
-121,275
-0.01%
0.56%
Current price: $0.87 71.19% Reported price*: $3.02
2018 Q1 (1 result)
Bill Miller
-0.91%
-46,300
-0.01%
0.85%
Current price: $0.87 77.81% Reported price*: $3.92
2017 Q4 (1 result)
Bill Miller
+4.65%
+225,890
+0.04%
0.91%
Current price: $0.87 78.99% Reported price*: $4.14
2017 Q3 (1 result)
Bill Miller
-1.38%
-68,100
-0.02%
1.37%
Current price: $0.87 85.83% Reported price*: $6.14
2017 Q2 (1 result)
Bill Miller
+0.02%
+1,135
+0.00%
1.39%
Current price: $0.87 86.01% Reported price*: $6.22
2017 Q1 (1 result)
Bill Miller
+0.50%
+24,600
+0.01%
1.62%
Current price: $0.87 86.28% Reported price*: $6.34
2016 Q4 (1 result)
Bill Miller
-2.10%
-105,200
-0.03%
1.40%
Current price: $0.87 83.74% Reported price*: $5.35
2016 Q2 (1 result)
Bill Miller
-8.46%
-462,600
-0.16%
1.78%
Current price: $0.87 84.15% Reported price*: $5.49
2016 Q1 (1 result)
Bill Miller
+14.07%
+674,625
+0.25%
2.01%
Current price: $0.87 88.28% Reported price*: $7.42
2015 Q4 (1 result)
Bill Miller
+21.25%
+840,299
+0.27%
1.52%
Current price: $0.87 89.53% Reported price*: $8.31
2015 Q3 (2 results)
Bill Miller
+13.69%
+476,050
+0.18%
1.52%
Daniel Loeb
-100.00%
-1,950,000
-0.23%
0.00%
Current price: $0.87 90.34% AVG reported price*: $9.01
2015 Q2 (3 results)
Daniel Loeb
buy
+1,950,000
+0.23%
0.00%
Bill Miller
+15.92%
+477,547
+0.22%
1.58%
Chase Coleman III
-100.00%
-200,000
-0.02%
0.00%
Current price: $0.87 92.75% AVG reported price*: $12.00
2015 Q1 (2 results)
Chase Coleman III
buy
+200,000
+0.02%
0.00%
Bill Miller
buy
+3,000,000
+1.22%
1.22%
Current price: $0.87 91.92% AVG reported price*: $10.77
29 of 29

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.